Clinical Trials Logo

Filter by:
NCT ID: NCT00802178 Completed - Parkinson Disease Clinical Trials

First Presentation of Parkinson Disease Patients to Neurologist

Start date: February 2006
Phase: N/A
Study type: Observational

In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time

NCT ID: NCT00801957 Completed - Atopic Dermatitis Clinical Trials

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

Start date: March 2003
Phase: Phase 2
Study type: Interventional

Seven-month study in pediatric patients (2-11 years) with moderate to severe AD who were considered to benefit from vaccination to prevent invasive disease caused by Neisseria meningitides serogroup C.

NCT ID: NCT00801944 Completed - Clinical trials for Urinary Bladder, Overactive

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms

SUNRISE
Start date: April 2004
Phase: Phase 3
Study type: Interventional

Prospective, double-blind, double-randomised, 2-arm parallel group study. Optimal dose increase. Primary efficacy assessment of OAB symptoms by patient diaries.

NCT ID: NCT00801853 Completed - Asthma Clinical Trials

A Study of the Treatment-Sparing Effects of AEROVANTâ„¢ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL

Start date: March 2009
Phase: Phase 2
Study type: Interventional

A multi-center, Phase IIb, double-blind, randomized, placebo controlled, parallel-group, repeated-dose study in male and female patients with moderate to severe asthma in which patients will be stabilized on AEROVANT then doses of inhaled corticosteroids and LABA will be tapered. The hypothesis is that AEROVANT will improve asthma symptom control and decrease the need for inhaled corticosteroids and LABA, thus improving exacerbation incidence compared to placebo. Incidence of asthma exacerbation is the primary endpoint.

NCT ID: NCT00800384 Completed - Clinical trials for Ventricular Tachycardia

Shockless Implant Evaluation

SIMPLE
Start date: January 2009
Phase: N/A
Study type: Interventional

This trial will assess the safety of defibrillator testing and the influence of defibrillation testing on the efficacy of clinical shocks. The trial will test the hypothesis that implantable cardioverter defibrillator (ICD) implantation without defibrillation testing (DT) is non-inferior to implantation with testing against the composite endpoint of ineffective first appropriate clinical shock or arrhythmic death. It will also test the hypothesis, that defibrillation testing increases the peri-operative (30 days) complication rate of ICD implantation.

NCT ID: NCT00799903 Completed - Atherosclerosis Clinical Trials

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

STABILITY
Start date: December 2008
Phase: Phase 3
Study type: Interventional

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.

NCT ID: NCT00799266 Completed - Osteoporosis Clinical Trials

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

Start date: December 4, 2008
Phase: Phase 3
Study type: Interventional

This study was designed to evaluate the efficacy and safety of zoledronic acid compared to placebo in osteoporotic children treated with glucocorticoids

NCT ID: NCT00790933 Completed - Ulcerative Colitis Clinical Trials

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

GEMINI LTS
Start date: May 22, 2009
Phase: Phase 3
Study type: Interventional

The purpose of this multicenter, open-label study is to collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (MLN0002) administration.

NCT ID: NCT00790907 Completed - Clinical trials for Acute Coronary Syndrome

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)

FUTURA/OASIS 8
Start date: February 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the safety of two different dose regimens of unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction) who have been initially treated with fondaparinux.

NCT ID: NCT00790088 Completed - Clinical trials for Diabetes Mellitus, Type 1

INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy

Start date: February 2009
Phase:
Study type: Observational

The aim of the project is to document the international routine practice in sensor usage in patients treated with sensor-augmented pump therapy and to assess which variables (e.g. training of patients, frequency of sensor usage etc) are associated with an improvement in clinical outcome(s) from the start of the sensor use to the end of the follow-up period.